Trends in use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infections, United States, 2012-2017

BACKGROUND: Pre-exposure prophylaxis (PrEP) with oral TDF/FTC reduces the risk of HIV infection by >90% when taken as prescribed. Trends in prevalence of PrEP use, which account for persons who have stopped PrEP, increased through 2016, but have not been described since. METHODS: Annual prevalenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Epidemiol
Main Authors: Sullivan, Patrick S, Giler, Robertino Mera, Mouhanna, Farah, Pembleton, Elizabeth, Guest, Jodie, Jones, Jeb, Castel, Amanda, Yeung, Howa, Kramer, Michael, McCallister, Scott, Siegler, Aaron
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286244/
https://ncbi.nlm.nih.gov/pubmed/30037634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annepidem.2018.06.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados